Company

Sino Biopharmaceutical Ltd

Headquarters: Wan Chai, Hong Kong

Employees: 24,443

CEO: Mr. Yi Li

HKEX: 1177 +2.29%

Market Cap

HK$62.80 Billion

HKD as of Jan. 1, 2024

US$8.04 Billion

history Market Cap History

Sino Biopharmaceutical Ltd market capitalization over time

Evolution of Sino Biopharmaceutical Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Sino Biopharmaceutical Ltd

Detailed Description

Sino Biopharmaceutical Limited, an investment holding company, together with its subsidiaries, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates in three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's principal products include hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; oncology medicines comprising Saiweijian injections, Qingkeshu tablets, Qianping injections, Anxian capsules, Yinishu tablets, Genike capsules, Shoufu tablets, Jizhi tablets, and Leweixin injection; cardio-cerebral medicines, including Yilunping tablets, Tuotuo tablets, Sacubatro/Valsartan tablets, Tolvaptan tablets, Rivaroxaban tablets, Edaravone injections, Esmolol Hydrochloride injections, Esmolol Hydrochloride and Sodium Chloride injections, Polidocanol injections, Sacubitril Valsartan Sodium tablets, Urapidil Hydrochloride injections, and Kaina tablets; and orthopedic medicines, such as Gaisanchun capsules, Taiyan tablets, Zoledronic Acid injections, and Yigu injections. Its principal products also comprise digestive system medicines that consists of Aisuping injections, Getai tablets, and Deyou granules; anti-infectious medicines that include Tianjie injections, Fengruineng injections, Tianli injections, and Tianming injections; respiratory system medicines, such as Tianqingsule inhalation powder; and others comprising Debaian cataplasms, and Qingliming injections. In addition, the company engages in property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management consultancy services; and outpatient and surgical procedure. Further, it manufactures, sells, and distributes health food; and develops medical technology. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Top 1-year algo backtest: +240.10%

$10,000 in February 2023 would now be $34,010 by following it 5 minutes per day at market close.

How much did you gain in the last 12 months?

Stocks & Indices

Sino Biopharmaceutical Ltd has the following listings and related stock indices.


Stock: HKEX: 1177 wb_incandescent

Stock: FSX: SMZU wb_incandescent

Stock: OTC: SBHMY wb_incandescent

Stock: OTC: SBMFF wb_incandescent

Stock: FSX: SMZ1 wb_incandescent

Details

Headquarters:

Office Tower

Unit 09, 41st Floor, Room 4109 Convention Plaza 1 Harbour Road

Wan Chai, None

Hong Kong

Phone: 852 2802 9886

Fax: 852 2880 0847